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Introduction
Accurate prediction of the functional severity for uncertain 
variants and novel mutations as relating to disease is of great 
importance to medicine and biology. Bridging the genotype-
phenotype gap for uncertain gene variants and novel mutations 
provides a prime opportunity for application of informatics methods. 
The process of determining the severity of a mutation is costly and 
time consuming and informatics tools and methods may aid to bridge 
this genotype-phenotype gap. If proven sufficiently reliable, it may 
ultimately be possible to use these methods as diagnostic tools. At 
a minimum they can help to prioritize the studies of the mutations 
more likely associated with severe prognosis.
There are established methods for predicting mutation severity 
based on substitution penalties, structural disruption, or sequence 
homology (ortholog conservation), such as PolyPhen [1], SIFT [2] 
and MutPred [3]. However, prediction algorithms are not always in 
agreement with curated data or each other [4-6]. Thus, there are 
opportunities to explore the use of other informatics approaches 
to this problem. Machine learning methods that can be trained on 
data available in well-curated gene variant collections are promising 
tools to improve the predictive capabilities available to the research 
community.
While many existing models to predict severity of mutations are 
based on sequence similarities based on phylogenetic arguments, this 
approach attempts to use physicochemical properties of amino acids. 
Numerical values for amino acid properties have been previously 
reported as descriptors for classification [7,8]. Our assumption is that 
because the physicochemical properties of amino acids define their 
binding properties, they may be better descriptors of the differences 
between wild type and mutant.
The RET oncogene is located on chromosome 10q11, with 21 
exons coding a full length protein of 1,114 amino acids. Conserved 
functional domains found within the protein (RET_HUMAN, http://
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Abstract
Although many reported mutations in the RET oncogene have been directly associated with hereditary thyroid 
carcinoma, other mutations are labelled as uncertain gene variants because they have not been clearly associated with 
a clinical phenotype. The process of determining the severity of a mutation is costly and time consuming. Informatics 
tools and methods may aid to bridge this genotype-phenotype gap. Towards this goal, machine-learning classification 
algorithms were evaluated for their ability to distinguish benign and pathogenic RET gene variants as characterized 
by differences in values of physicochemical properties of the residue present in the wild type and the one in the 
mutated sequence. Representative algorithms were chosen from different categories of machine learning classification 
techniques, including rules, bayes, and regression, nearest neighbour, support vector machines and trees. Machine-
learning models were then compared to well-established techniques used for mutation severity prediction. Machine-
learning classification can be used to accurately predict RET mutation status using primary sequence information only. 
Existing algorithms that are based on sequence homology (ortholog conservation) or protein structural data are not 
necessarily superior.
RET Codon Thyroidectomy Phenotype
883, 918 within first 6 months MEN 2B
609, 611, 618, 620, 630, or 634 within first 5 years MEN 2A
768, 790, 804, or 891 within 5 - 10 years FMTC
aGuidelines from 7th International Workshop on MEN2. [20]
Table 1: RET mutation guided therapy for surgical removal of the thyroida.
Figure 1: RET protein domains. Schematic view of the RET oncoprotein 
showing conserved domains of signal peptide (SP), cadherin repeat domains 
(CAD), cysteine rich region (CYS), transmembrane domain (TM), and protein 
tyrosine kinase (Kinase) where reported variants associate to three specific 
disease phenotypes; familial medullary thyroid cancer (FMTC), multiple 
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www.uniprot.org/uniprot/P07949) include a signal peptide, cadherin 
repeat domains, transmembrane domain, and protein tyrosine 
kinase [9]. Mutations in the RET oncogene (Rearranged during 
Transfection; OMIM# 164761) have been directly associated with 
Multiple Endocrine Neoplasia type 2 (MEN2), a hereditary thyroid 
carcinoma syndrome [10,11]. Although well known mutations often 
guide patient therapy and surgical options [12], other RET sequence 
mutations vary in functional severity. Some are pathogenic, some 
are benign, and some are of unknown significance. Curated RET 
oncogene mutations for MEN2 have been recently reported, many of 
which have documented phenotype outcomes [13]. (Figure 1) displays 
reported disease causing variants as associated with different MEN2 
phenotypes. (Table 1) summarizes mutation-guided therapy for 
thyroid cancer where surgical removal of thyroid is guided by codon 
position of the RET mutation.
Accurately predicting the mutation severity for gene variants 
in the RET oncogene could help clinicians identify patients less 
likely to respond to standard treatments, assist patients when 
making informed decisions about their care, and aid researchers in 
understanding mechanisms of disease severity.
Here we examine the hypothesis that novel informatics tools 
can take advantage of well-curated gene variant collections, utilizing 
physicochemical properties of the amino acids in the coded proteins to 
determine mutation severity. This study evaluates the performance of 
machine-learning classification algorithms for predicting mutational 
severity in RET oncogene variants with known genotype-phenotype 
association when using representative chemical, physical, energetic, 
and conformational properties of amino acids as descriptors of the 
mutation.
Methods
A curated set of non-synonymous RET mutations with known 
phenotype severity (“pathogenic” or “benign”), publicly available at 
http://www.arup.utah.edu/database/, [13] was used to train and test 
representative machine learning classification algorithms. Archived 
RET gene variants were accessed from this database in January 2010. 
Sequence variants were verified for their position within the RET 
gene and named following standard Human Genome Organisation 
(HUGO) nomenclature. RET mutations were characterized by 
the absolute differences between the values of 544 amino acid 
properties (AAIndex v9.4) of the residue present in the wild type 
and the one in the mutated sequence [14,15]. The Correlation-based 
Feature Subset Selection algorithm [16], together with the Best 
First (greedy hillclimbing) search method, were used to identify the 
subset of properties that best differentiated benign mutations from 
pathogenic ones, based on the amino acid changes in RET. After 
feature selection was performed on training sets, selected properties 
specific to each training set (k=3) were carried forward as attributes 
for classification. Thus, each mutation was described by an array 
of variables, corresponding to the absolute value of the difference 
between the value of the property in the amino acid present in the 
wild type and the one in the mutant. Due to the limited amount of 
clinically curated variants available publically, cross fold validation 
(k=3) was used to train and test classification of disease phenotype. 
The sample set (n=104) used 58 pathogenic variants specific to 
Table 2: Feature selection (n=23) from 544 amino acid properties from AAindex.
Propertya Original Source PubMed ID
alpha NH chemical shifts Bundi (1979) 7881270
Normalized frequency of C terminal helix Chou (1978) 364941
Normalized frequency of chain reversal R Tanaka (1977) 557155
Normalized positional frequency at helix termini N2 Aurora-Rose (1998) 9514257
Partition coefficient Garel (1973) 4700470
Relative preference value at C2 Richardson (1988) 3381086
Relative preference value at N1 Richardson (1988) 3381086
Weights for beta sheet at the window position of 0 Qian (1988) 3172241
Amino acid distribution Jukes (1975) 237322
Average relative fractional occurrence in A0(i) Rackovsky (1982) 0903736
Average relative probability of inner beta sheet Kanehisa (1980) 7426680
Composition Grantham (1974) 4843792
Effective partition energy Miyazawa (1985) 2004114
Free energy in alpha helical region Munoz (1994) 7731949
Frequency of the 3rd residue in turn Chou (1978) 364941
Helix formation parameters (delta delta G) O Neil (1990) 2237415
Hydrophobicity Prabhakaran (1990) 2390062
Membrane buried preference parameters Argos (1982) 7151796
Normalized frequency of beta structure Nagano 1973 4728695
Normalized frequency of coil Nagano 1973 4728695
Normalized positional frequency at helix termini Cc Aurora-Rose (1998) 9514257
STERIMOL maximum width of the side chain Fauchere (1988) 3209351
Zimm Bragg parameter sigma x 1.0E4 Sueki (1984) 1004141
aAccessed August 2010 from http://www.genome.jp/aaindex/




Algorithm Algorithm Algorithm Positive
Name Sensitivity Specificity Predictive Value
ZeroR 1.00 0.00 0.557
IBk 0.896 0.674 0.776
RandomForest 0.776 0.739 0.789
SMO 0.914 0.696 0.791
SimpleLogistic 0.826 0.761 0.814
NaiveBayes 0.827 0.783 0.827
PolyPhena 0.597 0.920 0.541
SIFTb 0.816 0.821 0.779
MutPredc 0.767 0.823 0.843
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MEN2 phenotype and 46 benign variants. The data set only used 
nonsynonymous variants where one amino acid was substituted for 
another. Because of the limited sample size, we chose to perform 
cross validation rather than the ideal method of holding data separate 
for external validation.
For this study, five different machine-learning classification 
algorithms were evaluated including: ZeroR (zero rules), bayes 
(NaiveBayes), regression (SimpleLogistic), support vector machine 
(SMO), k nearest neighbor (IBk), and trees (RandomForest). Machine-
learning classification algorithms with their respective default 
settings as implemented in the Weka software package (v3.6) were 
used in this study [17]. Because “accuracy” is a term often plagued 
with misinterpretation, we choose to evaluate algorithm performance 
using previously reported and less ambiguous values of sensitivity, 
specificity, and positive predictive value [18].
Finally, the above classification models were also compared 
to existing mutation prediction algorithms based on sequence 
homology, amino acid substitution penalties or structural disruption 
using the full set of RET mutations with their curated outcomes. The 
SIFT algorithm is available on-line at http://sift.jcvi.org/ and gives 
outcomes of “tolerated” (meaning predicted benign) and “affects 
protein function” (meaning predicted pathogenic). PolyPhen was 
accessed at http://genetics.bwh.harvard.edu/pph and has outcomes of 
“benign” and “probably damaging” (meaning predicted pathogenic). 
MutPred is hosted at http://mutdb.org/mutpred and calculates the 
probability of a deleterious mutation with corresponding hypothesis 
of disrupted molecular mechanism when found. These algorithms 
were accessed during July/August 2010 and evaluated using their 
respective default settings.
Results
Utilizing a strategy of k-fold cross validation (k=3), the correlation-
based feature selection chose 23 properties from the original 544 
amino acid attributes in AAindex. These descriptors are summarized 
in (Table 2). Overall, 8 properties were chosen using feature selection 
in 3 out of 3 folds, while some 15 properties were seen in 2 out of 3 
folds. Amino acid properties relating to hydrophobicity or membrane 
buriedness, as well as positional or structural frequency seem to be 
representative of the features selected by this methodology.
To evaluate classifier performance, the weighted average from 
3 fold cross validation of sensitivity (true positive rate), specificity 
(true negative rate), and positive predictive value (precision) were 
calculated for each classifier algorithm. Classifier performance is 
summarized in (Table 3) as ranked by positive predictive value (PPV) 
or the percentage of variants classified as pathogenic that actually 
were pathogenic. For this data set, ZeroR (zero rules - which selects 
the majority class by default), yielded a baseline performance of 
55.7%. The nearest neighbor, random forest, support vector machine, 
and regression models gave similar performance to each other with 
77.6%, 78.9%, 79.1%, and 81.4% respectively. Naïve Bayes was the best 
performing algorithm with a PPV of 82.7%, a gain in performance 
of 27% over the ZeroR classifier. The machine learning algorithms 
constructed models that primarily used positional frequency and 
hydrophobicity related properties such as frequency of the 3rd 
residue in turn or membrane buried preference parameters as leading 
factors to classify the mutations. This may reinforce the importance 
of mutations in key residues responsible for proper transmembrane 
placement and strategic cysteine residues responsible for normal 
kinase dimerization function [19]. In other words, location of the 
change is not equal across the length of the protein sequence. 
Amino acid substitutions in key “hot spot” areas are thus more 
likely to result in pathogenic gain of function effects. Compared to 
the existing mutation prediction algorithms, we found that all the 
classifiers used here performed better than or similar to the well 
established algorithms (Table 3). Analysis of the RET mutations using 
PolyPhen correctly identified 68 out of 104 mutations as compared 
to the curated database entries (65% agreement). The MutPred 
algorithm performed similarly with 64% agreement (67 out of 104). 
It was unable, however, to complete predictions for 33 of the 104 
mutations, although results for the remaining curated entries yielded 
67 out of 71 (94% agreement). SIFT analysis correctly classified 
75 of 104 cases when compared to the curated database for 72% 
agreement. To demonstrate disagreement when comparing existing 
algorithms to curated outcomes, results for selected RET mutations 
are summarized in (Table 4). Discrepancies between the known 
phenotype and the existing prediction algorithms seemed to occur in 
cysteine related substitutions or where alignment to RET orthologs 
was not well conserved.
Discussion
One example that highlights the usefulness of predicting mutation 
severity was found in the RET codon 609. Although several changes 
in the codon 609 are known to be pathogenic, the variant C609S 
is currently listed as an uncertain variant in the curated database. 
The machine learning classifiers along with the mutation prediction 
tools labeled this variant as “predicted pathogenic”, “probably 
damaging” (SIFT), “affects protein function” (PolyPhen) and mutation 
(0.90), with a gain of glycosylation site (MutPred). This example 
underscores the utility of computational prediction of mutations and 
suggests a need for careful evaluation of this C609S variant, including 
additional family outcome studies or further molecular confirmation 
of the resulting phenotype. When mutations are characterized by the 
difference between the values in several amino acid properties in the 
wild type and the mutated sequence, machine-learning classification 
can be used to accurately predict RET mutation status using primary 
sequence information only. Existing algorithms that are based on 
sequence homology (ortholog conservation) or protein structural 
data are not necessarily superior - at least for this specific genotype-
phenotype. These results indicate that using physiochemical 
properties of amino acids to characterize mutations is important 
and may be more relevant than evolutionary sequence conservation. 
Furthermore, the attributes found in AAIndex – in combination with 
feature selection - are a viable source of descriptors for use with 
machine learning tools and mutation prediction. Finally, several 
different types of algorithms worked similarly well, pointing to the 
robustness of this methodology.
RET Gene Varianta PolyPhen SIFT MutPred
Curated Outcome Predictionb Predictionc Predictiond
G533C (pathogenic) probably damaging affects function Not available
C609S (uncertain) probably damaging affects function deleterious (0.90)
C611S (pathogenic) probably damaging affects function deleterious (0.90)
C618G (pathogenic) probably damaging tolerated deleterious (0.88)
C620R (pathogenic) benign tolerated deleterious (0.75)
C630R (pathogenic) probably damaging tolerated deleterious (0.70)
D631Y (pathogenic) probably damaging affects function deleterious (0.69)
C634L (pathogenic) probably damaging tolerated deleterious (0.69)
S649L (pathogenic) probably damaging tolerated deleterious (0.66)
G691S (benign) benign tolerated benign (0.20)
aCurated RET variants from http://www.arup.utah.edu/database/MEN2/MEN2_
welcome.php
bAnalyzed with default settings at http://genetics.bwh.harvard.edu/pph
cAnalyzed with default settings at http://sift.jcvi.org
dAnalyzed with default settings at http://mutdb.org/mutpred
Table 4: Comparison of mutation prediction for selected RET mutations using 
PolyPhen, SIFT and MutPred.
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